This article is more than 5 years old. Information may no longer be current.

Titan Spine receives patents for interbody fusion portfolio

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Titan Spine announced it has been awarded five new patents for the design of the company’s Endoskeleton line of interbody devices as well as various aspects of composite devices featuring a combination of metal and polymer materials, such as polyetheretherketone.

“The addition of these thirteen patents in 2013 exemplifies our continued commitment to protect and broaden our intellectual property in the interbody fusion space,” Kevin Gemas, president of Titan Spine, stated in a company press release. “Several of these new patents extend to composite interbody device designs even though they do not align with our philosophy of the superiority of an interbody device constructed entirely of titanium. We made the decision to include them as part of our comprehensive intellectual property approach.”